会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • NEW CHEMICAL INHIBITORS OF BACTERIAL HEPTOSE SYNTHESIS, METHODS FOR THEIR PREPARATION AND BIOLOGICAL APPLICATIONS OF SAID INHIBITORS
    • 细菌肝素合成新化学抑制剂,其抑制剂的制备和生物应用方法
    • WO2008038136A2
    • 2008-04-03
    • PCT/IB2007/003276
    • 2007-09-25
    • MUTABILIS SAESCAICH, SoniaDENIS, AlexisMOREAU, FrançoisGERUSZ, VincentDESROY, Nicolas
    • ESCAICH, SoniaDENIS, AlexisMOREAU, FrançoisGERUSZ, VincentDESROY, Nicolas
    • C07D417/14C07D401/12C07D405/12C07D417/12
    • The invention relates to new compounds having heptose synthesis inhibitory properties, of formula (I) or a pharmaceutically acceptable salt, or prodrug thereof, wherein A is an aryl or heterocycle, optionally substituted by one or several identical or different R such as H, C1-C10 alkyl, C1-C10 alkyl-OR 1 , C1-C10 alkyl-NR 1 R 1 , alkoxy, hydroxy, thioalkyl, aryl, heterocycle, halogen, nitro, cyano, CO 2 R 1 , NR 1 R 1 , NR 1 C(O)R 1 , C(O)NR 1 R 1 , NR 1 C(S)R 1 , C(S)NR 1 R 1 , SO 2 NR 1 R 1 , SO 2 R 1 , NR 1 SO 2 R 1 , NR 1 C(O)NR 1 R 1 , NR 1 C(O)OR 1 , NR 1 C(S)NR 1 R 1 , NR 1 C(S)OR 1 , R 1 C=NOR 1 , C(O)R 1 , aryloxy, thioaryl, alkenyl, alkynyl R1 identical or different is H or C1-C10 alkyl B 1 , B 2 , B 3 identical or not represent C, N, O, S to form a five-membered aromatic ring wherein from one to three carbon atoms are replaced by a heteroatom selected from S, O, N optionally substituted by one or several identical or different R such as defined above B 4 is C or N Y is H, C1-C10 alkyl, alkoxy, thio-alkyl, optionally substituted by one or several identical or different R such as defined above W is C, O or N, substituted or not by one or several C1-C10 alkyl radicals D is an heterocycle optionally substituted by one or several identical or different R such as defined above.
    • 本发明涉及具有式(I)的肝素合成抑制性质的新化合物或其药学上可接受的盐或前药,其中A是芳基或杂环,任选被一个或多个相同或不同的R如H,C1 -C 10烷基,C 1 -C 10烷基-OR 1,C 1 -C 10烷基-NR 1 R 1,烷氧基,羟基,硫代烷基,芳基 ,杂环,卤素,硝基,氰基,CO 2 R 1,NR 1 R 1,NR N, C(O)R 1,C(O)NR 1 R 1,NR 1, C(S)R 1,C(S)NR 1 R 1,SO 2 NR 3, 2个1,1个,1个,1个,2个,1个,1个,1个,1个,1个,3个, NR 1,NR 1,NR 1,NR 1,NR 1, 1个C(O)OR 1,NR 1 C(S)NR 1 R 1, ,NR 1 C(S)OR 1,R 1 C = NOR 1,C(O)R 芳氧基,硫代芳基,烯基,炔基R1相同或相同 不同的是H或C 1 -C 10烷基B 1,B 2,B 3 3相同或不表示C,N,O,S以形成 一个五元芳环,其中一至三个碳原子被选自任选被一个或多个相同或不同的R如上面定义的R 4取代的S,O,N的杂原子取代为C 或NY为H,任选被一个或几个相同或不同的R取代的C 1 -C 10烷基,烷氧基,硫代烷基,W如C,O或N,被一个或多个C 1 -C 10烷基取代或不被 D是任选被一个或多个相同或不同的R取代的杂环,如上所定义。
    • 5. 发明申请
    • PURINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS FOR PREVENTION OR TREATMENT OF BACTERIAL INFECTIONS
    • 嘌呤衍生物及其作为预防或治疗细菌感染的药物
    • WO2012172043A1
    • 2012-12-20
    • PCT/EP2012/061428
    • 2012-06-15
    • LABORATOIRE BIODIMATAMANYUK, DmytroDENIS, AlexisGERUSZ, VincentLEDOUSSAL, BenoîtBONVIN, YannickDESROY, NicolasGOLD, JohanMOREAU, FrançoisOXOBY, Mayalen
    • ATAMANYUK, DmytroDENIS, AlexisGERUSZ, VincentLEDOUSSAL, BenoîtBONVIN, YannickDESROY, NicolasGOLD, JohanMOREAU, FrançoisOXOBY, Mayalen
    • C07D473/32A61K31/52A61P31/04
    • C07D473/32
    • The invention relates to the compounds of general formula (I) and their addition salts thereof with acids and bases: wherein A is phenyl, naphthyl and 5-10 membered monocyclic or bicyclic unsaturated heterocycle, optionally substituted by a group R1 which is as defined in the application and is itself optionally substitutes by a group R2 which is as defined in the application and is itself optionally substituted by a group R3 which is defined in the application, Y and W, identical or different, are H, (C 1 -C 6 ) alkyl, (C 2 -C 6 ) alkenyl, (C 2 -C 6 ) alkynyl, phenyl or 4-10 monocyclic or bicyclic saturated or unsaturated heterocycle, optionally substituted by R1, or Y and/or W form a 4-10 membered cycle with R1, or Y and W form with N a saturated or unsaturated nitrogenous 4-10 membered mono, bi or tricyclic system, fused, bridged or spiro system, said system being optionally substituted by R1, said system being different from morpholine, with the proviso that when Y and A are phenyl or heterocycle, W is not H, a process and intermediates for their preparation and their use in the antibacterial prevention and therapy, used alone or in association with antibacterials, antivirulence agents or drugs reinforcing the host innate immunity, and pharmaceutical compositions and associations containing them.
    • 本发明涉及通式(I)的化合物及其与酸和碱的加成盐:其中A是苯基,萘基和5-10元单环或双环不饱和杂环,任选地被如下定义的基团R 1所取代: 本申请本身可以任选地被如申请中定义的基团R2取代,并且本身任选被在应用中定义的基团R 3取代,Y和W相同或不同,为H,(C 1 -C 6) 烷基,(C 2 -C 6)烯基,(C 2 -C 6)炔基,苯基或4-10单环或双环饱和或不饱和杂环,任选被R 1取代,或Y和/或W与R 1形成4-10元环, 或Y和W与N形成饱和或不饱和的含氮4-10元单,双或三环系统,稠合,桥连或螺环系统,所述系统任选被R 1取代,所述系统不同于吗啉,条件是当 Y和A是苯基或杂环 W不是H,它们的制备方法和中间体以及它们在抗菌预防和治疗中的用途,其单独使用或与抗菌剂,抗毒素剂或增强宿主先天免疫力的药物联合使用,以及含有它们的药物组合物和组合物。
    • 10. 发明申请
    • NOUVEAUX DERIVES DE THIOPHENE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
    • 新型噻吩衍生物,其制备方法及含有其的药物组合物
    • WO2004018448A1
    • 2004-03-04
    • PCT/EP2003/008750
    • 2003-08-07
    • WARNER-LAMBERT COMPANY LLCDUBLANCHET, Anne-claudeCOMPERE, DelphineCLUZEAU, PhilippeBLAIS, StephaneDENIS, AlexisDUCROT, PierreCOURTE, KarineDESCAMPS, Sophie
    • DUBLANCHET, Anne-claudeCOMPERE, DelphineCLUZEAU, PhilippeBLAIS, StephaneDENIS, AlexisDUCROT, PierreCOURTE, KarineDESCAMPS, Sophie
    • C07D333/38
    • C07D409/10C07D333/38C07D409/12C07D413/10C07D417/10C07D491/10
    • Composés de formule (I) caractérisés en ce que • X représente oxygène ou soufre, • Y représente oxygène,-NH ou -N(C 1 -C 6 )alkyle, • R a représente hydrogène, halogène, (C 1 -C 3 )alkyle, hydroxy, ou (C 1 -C 3 )alkoxy, • R b représente hydrogène, halogène, ou (C 1 -C 3 )alkyle, • A représente phényle, pyridyle, (C 5 -C 6 )cycloalkyle ou (C 5 -C 6 )cycloalkènyle, • R 1 et R 2 représentent chacun un groupement choisi parmi hydrogène, halogène, cyano, nitro, halogénoalkyle, halogénoalkoxy, alkyle, alkènyle, alkynyle, -OR 4 , -NR 4 R 5 , -S(O) n R 4 , -C(O)R 4 , -C0 2 R 4 , -O-C(O)R 4 , -C(O)NR 4 R 5 , -NR 5 -C(O)R 4 , -NR 5 -S0 2 R 4 , -T-CN, -T-OR 4 , -T-OCF 3 , -T-NR 4 R 5 , -T-S(O) n R 4 , -T-C(O)R 4 , -T-C0 2 R 4 , -T-O-C(O)R 4 , -T-C(O)NR 4 R 5 , -T-NR 4 -C(O)R 5 , -T-NR 4 -S0 2 R 5 , -R 6 , et -T-R 6 dans lesquels n, T, R 4 , R 5 et R 6 sont tels que définis dans la description, • R 3 représente un groupement -R 7 ou -U-R 11 , dans lesquels R 7 représente hydrogène, alkyle, aryle, cycloalkyle ou hétérocycle, U représente une chaîne alkylène linéaire ou ramifiée, et R 11 , est tel que défini dans la description, leurs isomères optiques ou leurs sels d'addition à un acide ou à une base pharmaceutiquement acceptable, et leur utilisation en tant qu'inhibiteur de métalloprotéinase et plus spécifiquement de la métalloprotéinase -12.
    • 本发明涉及具有式(I)的化合物,其特征在于:X表示氧或硫; Y表示氧,-NH或-N(C 1 -C 6)烷基; R a表示氢,卤素,(C 1 -C 3)烷基,羟基或(C 1 -C 3)烷氧基; R b表示氢,卤素或(C 1 -C 3)烷基; A表示苯基,吡啶基,(C5-C6)环烷基或(C5-C6)环烯基; R1和R2各自表示选自氢,卤素,氰基,硝基,卤代烷基,卤代烷氧基,烷基,烯基,炔基,-OR4,-NR4R5,-S(O)nR4,-C(O)R4,-CO2R4, -OC(O)R4,-C(O)NR4R5,-NR5-C(O)R4,-NR5-SO2R4,-T-CN,-T-OR4,-T-OCF3,-T-NR4R5,-TS (O)n R 4,-TC(O)R 4,-T-CO 2 R 4,-TOC(O)R 4,-TC(O)NR 4 R 5,-T-NR 4 -C(O)R 5,-T-NR 4 -SO 2 R 5 - R6和-T-R6,其中n,T,R4,R5和R6如说明书中所定义; 并且R 3表示-R 7或-U-R 11基团,其中R 7表示氢,烷基,芳基,环烷基或杂环,U表示直链或支链亚烷基链,R 11如说明书中所定义。 本发明还涉及其光学异构体或其具有药学上可接受的碱或酸的加成盐。 本发明还涉及所述化合物作为金属蛋白酶抑制剂,更具体地说是金属蛋白酶-12的用途。